Evaluate patient characteristics that are predictors of treatment response and outcomes in gestational diabetes
Retrospective cohort of 265 women with gestational diabetes treated with diet/metformin and/or insulin in a single centre over 2 years.
Multinomial logistic regression showed that (after adjusting for age and ethnicity) women who were of normal weight were more likely to be on diet and women who were obese were more likely to be on metformin or metformin and insulin(p = 0.014). Women who were obese were twice more likely to have labour induced than those with normal weight. Onset of labour was the only parameter significantly associated with a treatment modality among the three groups (p < 0.001). There was no difference in the incidence of large for gestational age, neonatal admission, shoulder dystocia or still birth between the three groups.
Maternal BMI appears to be the only parameter that is predictive of need for treatment with metformin/insulin and the modality of treatment does not have an effect on maternal and neonatal outcomes.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to European Journal of Obstetrics and Gynecology and Reproductive Biology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Hyperglycemia pregnancy outcome study: associations with neonatal anthropometrics.Diabetes Care. 2009; 58: 453-459
- Foetal and neonatal complications in gestational diabetes: perinatal mortality, congenital malformations, macrosomia, shoulder dystocia, birth injuries, neonatal complications.Diabetes Metab. 2010; 36: 617-627
- Maternal outcomes and follow-up after gestational diabetes mellitus.Diabet Med. 2014; 31: 292-301
- Long term health outcomes in offspring born to women with diabetes in pregnancy.Curr Diabetes Reports. 2014; 14: 489
- A low disposition index in adolescent offspring of mothers with gestational diabetes: a risk marker for the development of impaired glucose tolerance in youth.Diabetologia. 2014; 57: 2413-2420
- Can we predict the need for pharmacological treatment according to demographic and clinical characteristics in gestational diabetes?.The Journal of Maternal-Fetal & Neonatal Medicine. 2016; 29: 2062-2066
- Overweight and obese in gestational diabetes:The impact on pregnancy outcome.Am J Obstet Gynecol. 2005; 192: 1768-1776
- Gestational diabetes mellitus: who requires insulin therapy?.Aust N Z J Obstet Gynaecol. 2011; 51: 432-436
- Risk Factors That can Predict Antenatal Insulin Need in Gestational Diabetes.J Clin Med Res. 2013; 5: 381-388
- Can common clinical parameters be used to identify patients who will need insulin treatment in gestational diabetes mellitus?.Diabetes Care. 2011; 34: 2214-2216
- Fetal macrosomia—a continuing obstetric challenge.Biol Neonate. 2006; 90: 98-103
- Factors influencing risk of macrosomia in women with gestational diabetes mellitus undergoing intensive diabetic care.Diabetes Res Clin Practice. 2008; 80: 405-410
Published online: November 20, 2017
Accepted: November 19, 2017
Received in revised form: November 18, 2017
Received: July 1, 2017
© 2017 Elsevier B.V. All rights reserved.